Cover Story

  • ‘We expect further fine tuning of the existing schemes and policies’

    Suresh Pareek, Managing Director, Ideal Cures The implementation of various schemes and policies by the NDA government has brought about a lot of fresh changes in the way things...

  • ‘Hoping that the future of Indian Pharma is brighter than before’

    Dr Ajit Dangi, President & CEO, Danssen Consulting While  most reforms carried out by the Modi Government in the past four and a half years were incremental in nature,...

  • ‘I expect more bold initiatives on macro-economic front’

    Dr Gopakumar G Nair, CEO, Gopakumar Nair Associates The Modi Government has been following a policy of concentrating on macro issues, leaving the micro management to the executive authorities....

  • ‘Funding for pharma companies might be a way to move forward’

    Dr Dinesh Dua, Chairman,Pharmexcil, Chairman, Entrepreneurship & Start Ups, CII North India,CEO & Director, Nectar Lifescience India is pharmacy to the world, supplying medicines to 195 countries, complying with...

  • ‘There is a definite need to support SME upgradation’

    Harish Jain, Secretary and Sunil Attavar, President, Karnataka Drugs & Pharmaceuticals Manufacturer’s Association There is no doubt that since 2014, from the time when the present NDA government has...

  • ‘We expect the new govt to reduce regulatory intervention’

    BR Sikri, Chairman, Fope First let me highlight the good things done by the present government.: Recently agreed to publish SQ (What is SQ) also in addition to ‘Not...

  • A report card and a wishlist

    Demonetisation, Swachh Bharat Abhiyan, Make in India, Digital India, Ayushmaan Bharat and implementation of GST have been the major highlights of the BJP-led government. The government also initiated policies...

  • Price cap on onco drugs: Will it have the desired impact?

    NPPA’s recent move to cap the price of 42 non-scheduled cancer drugs has evoked mixed reactions from the industry. While some berated it as a hasty decision, others have...

  • Honesty is still the best policy!

    Amit Rajan, Managing Director, Prosfora Technologies, says that instilling a culture of compliance in a pharma set up is about nurturing, training and development of all the staffs concerned,...

  • How to build a quality culture to meet GMP compliance?

    In order to maintain a quality culture, Rajashri Survase-Ojha, Founder and MD, RAAJ GPRAC advises that organisations must maintain an awareness of quality as a key cultural issue, make...

  • Upgrading knowledge and skills in cost-effective manner

    Rahul Guha, Partner and Director and India Lead, Healthcare Practice, BCG, gives an insight on identifying possible areas of intervention and structuring, training and upskilling programmes that can meet...

  • Quality: From compliance to culture

    As custodians to ensure patient safety, quality teams in pharma firms must have a mechanism not only to comply but to consistently comply, says Rashida Najmi, Senior Vice President,...

  • Building a culture of compliance

    Lingering cGMP issues underline the importance of hiring right, rigorous training and continuous oversight to consistently comply with safety norms

  • FEEDBACK TO PHARMA CXO SUMMIT 2019

  • Keynote address: Transforming pharma with disruptive technologies

    Shaunak Dave, CEO, Optel Asia gave a rousing key note address on the first day of Pharma CXO Summit 2019 which centred on the potential of Indian pharma industry....

  • Inaugural ceremony

    Following the successful first edition of the Pharma CXO Summit, The Indian Express (P) Ltd and Express Pharma, in association with the Optel Group, recently hosted its second edition...

  • Pharma CXO Summit 2019

    Leaders and experts come together to transform India Pharma Inc into a more value-driven industry with the help of disruptive technologies Inaugural ceremony Keynote address: Transforming pharma with disruptive...

  • Express Pharma Excellence Awards honour export leaders of India Pharma Inc

    This year's winners were chosen on the basis of exports turnover and exports growth rate

  • Enhancing patient engagement with technology

    The dawn of the digital era has enabled pharma companies to bring a paradigm shift in its interactions with doctors and patients. The panel discussion on ‘Enhancing Patient Engagement...

  • Patient safety with technology

    Bejon Misra, International Consumer Policy Experts and Founder, Safe Medicines India was the last speaker of Day 2. He gave a talk on how technology can play an important...

  • Industry 4.0: Driving efficient and intelligent manufacturing

    Rashmi Ranjan Patra, Independent Pharma Consultant gave a detailed presentation on the evolution from Industry 1.0 to Industry 4.0. Patra informed that Industry 4.0 will be defined by the...

  • Panel discussion: Advancements in pharma packaging technology

    Packaging has emerged as a crucial differentiator in the pharma industry. Therefore, the discussion on ‘Advancements in pharma packaging technology’ at Pharma CXO Summit 2019 probed and analysed how...

  • Panel discussion: Role of intelligent supply chains

    The role of an effective supply chain to become a major differentiator in the value chain, as companies seek the next phase of growth, is pivotal. And, pharma companies...

  • Keynote address: A harmonised approach to serialisation

    Sachidanantham Swaminathan, Chief General Manager, GS1 India, in his keynote address, gave a very insightful presentation on various pivotal aspects of the life sciences industry. He started his session...

  • Serialisation: From here to eternity

    Arjun Guha Thakurta gave an overview on the current regulatory frameworks in the world and explained the regulations and laws in the US and the EU with regards to...

  • Panel discussion: The future of pharma CIOs

    The role of CIOs has transitioned from that of a being who keeps the IT infrastructure running to someone who is attuned to the company’s technological needs to meet...

  • Panel discussion: Tech renaissance in pharma

    As the pharma sector undergoes a transformation, technology has become a key factor to gain a competitive advantage. Therefore, the first panel discussion at Pharma CXO Summit 2019 was...